Partners Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,079
Closed -$396K – 438
2026
Q2
$396K Hold
3,079
– – 0.39% 67
2026
Q1
$370K Buy
3,079
+25
+0.8% +$2.89K 0.38% 69
2025
Q4
$321K Buy
3,054
+50
+2% +$4.69K 0.34% 76
2025
Q3
$252K Sell
3,004
-501
-14% -$41.3K 0.25% 103
2025
Q2
$305K Hold
3,505
– – 0.35% 77
2025
Q1
$315K Sell
3,505
-700
-17% -$65.4K 0.36% 75
2024
Q4
$418K Buy
+4,205
New +$434K 0.48% 61

Other funds holding MRK

Partners Wealth Management's MRK Position: Q3 2026 in Review

Partners Wealth Management sold out of Merck (MRK) in Q3 2026, closing a stake of 3,079 shares — an estimated $396K sold.

Partners Wealth Management first reported a position in MRK in Q4 2024 and held it in 7 quarters. The position peaked at $418K in Q4 2024. 3,923 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Partners Wealth Management reported no remaining Merck position as of Q3 2026 after selling out during the quarter.
  • Partners Wealth Management sold 3,079 Merck shares in Q3 2026, an estimated $396K.
  • Partners Wealth Management first reported a position in Merck in Q4 2024 and held it in 7 quarters.
  • Partners Wealth Management's Merck position peaked at $418K in Q4 2024.
  • 3,923 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Partners Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.